For 2018, NHSN Antimicrobial Use (AU) and Antimicrobial Resistance (AR) (AUR) reporting have been identified as a new option for public health registry reporting under Meaningful Use Stage 3 (MU3). This measure applies to Eligible Hospitals. Beginning January 1, 2017, a facility enrolled in the National Healthcare Safety Network (NHSN) will be able to register their … Continue reading “Meaningful Use” Antimicrobial Use and Resistance (AUR)